SI-BONE (SIBN) EV/EBIT: History & Chart

SI-BONE, Inc.(SIBN)

Medical - Devices · Santa Clara, CA

$19.31-0.50 (-2.51%)

Delayed quote: Oct 6, 2026, 2:45 PM EDT

About SI-BONE, Inc.

SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.

Santa Clara, CA

376 employees

si-bone.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Laura A. Francis

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
SI-BONE, Inc. (SIBN)	$856.52M	N/A	N/A	N/A	N/A
SL Science Holding Ltd (SLBT)vs ›	$857.96M	N/A	N/A	N/A	N/A
Rigel Pharmaceuticals, Inc. (RIGL)vs ›	$863.17M	9.68x	6.42x	12.92x	12.92x
Pacific Biosciences of California, Inc. (PACB)vs ›	$843.28M	N/A	N/A	N/A	N/A
QuidelOrtho Corporation (QDEL)vs ›	$842.16M	N/A	33.92x	15.14x	22.68x
SpyGlass Pharma, Inc. Common Stock (SGP)vs ›	$840.68M	N/A	N/A	N/A	N/A
Beta Bionics, Inc. (BBNX)vs ›	$838.58M	N/A	N/A	N/A	N/A
Alumis Inc. (ALMS)vs ›	$838.72M	N/A	N/A	N/A	N/A
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$835.44M	N/A	76.83x	76.83x	76.83x
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$877.90M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

SI-BONE, Inc. (SIBN)

$856.52M

N/A

SL Science Holding Ltd (SLBT)vs ›

$857.96M

N/A

Rigel Pharmaceuticals, Inc. (RIGL)vs ›

$863.17M